Clinical Trials Logo

Clinical Trial Summary

Observational, feasibility study investigating biological aspects in patients with liver metastasis from colorectal cancer undergoing treatment with SIRT, by translational analysis of biological samples.


Clinical Trial Description

In this study, the investigators seek to investigate biological aspects in patients with colorectal cancer liver metastasis undergoing treatment with Selective Internal Radiation Therapy, by translational analysis of biological samples. SIRT will be conducted as per standard procedure at Aarhus University Hospital. Translational blood samples will be drawn pre-treatment and during follow up. The total cell free DNA level will be quantified in all samples. The samples will be analysed for tumour specific mutations such as the KRAS, BRAF and NRAS oncogenes. The investigators expect to include up to 30 patients. This is a purely observational translational study. Results will be analysed in relation to outcome data. The study is conducted in collaboration with: Department of Gastroenterology and Hepatology, Aarhus University Hospital Department of Radiology, Aarhus University Hospital Department of Nuclear Medicine, Aarhus University Hospital ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04491929
Study type Observational
Source Aarhus University Hospital
Contact Louise B Callesen, MD
Phone +4578462535
Email louicall@rm.dk
Status Recruiting
Phase
Start date November 1, 2020
Completion date September 30, 2028

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05775146 - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases Phase 2
Suspended NCT04108481 - Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer Phase 1/Phase 2
Recruiting NCT03562234 - The CLiFF Study: Change in Liver Function and Fat in Pre-operative Chemotherapy for Colorectal Liver Metastases
Recruiting NCT03732235 - TACE Associated to Systemic Bevacizumab for the Treatment of Refractory Liver Metastases From Colorectal Cancer
Recruiting NCT06126419 - Application of High-dose Insulin Therapy to Improve Liver Function and Regeneration N/A
Active, not recruiting NCT05616039 - I-FIGS Feasibility Study N/A
Not yet recruiting NCT06050200 - TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery N/A
Withdrawn NCT05175092 - Living Donor Liver Transplantation for CRC Liver Metastases N/A
Recruiting NCT04798898 - Improving Survival of COlorectal LIver Metastases by RFA-mediated Immunostimulation N/A
Not yet recruiting NCT06071052 - TACE Plus HAIC Combined With Regorafenib for Liver Metastasis of Colorectal Cancer Refractory to Standard Treatment Regimens N/A
Not yet recruiting NCT06053996 - Hepatopulmonary Radio-sterilization With Immunotherapy N/A
Enrolling by invitation NCT03444194 - Treatment Response Evaluation in Patients With Non-resectable Colorectal Liver Metastases A Feasibility Study N/A
Not yet recruiting NCT05884723 - Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis N/A
Not yet recruiting NCT06185556 - COLDFIRE-III Trial: Efficacy of Irreversible Electroporation and Stereotactic Body Radiotherapy for Perivascular and Peribiliary Colorectal Liver Metastases Phase 2/Phase 3
Recruiting NCT05755672 - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Recruiting NCT04595266 - Chemoembolization (Lifepearls-Irinotecan) in Patients With Colorectal Cancer and Metastatic Disease Phase 2
Recruiting NCT04701281 - Study of Intra-Arterial Oxaliplatin Plus Capecitabine to Treat Liver Metastases From Colorectal Cancer Phase 1/Phase 2
Recruiting NCT06200831 - Simultaneous vs. Staged Resection of Colorectal Cancer With Synchronous Liver Metastases N/A
Active, not recruiting NCT04046445 - Phase 1b Study to Evaluate ATP128, VSV-GP128 and BI 754091, in Patients With Stage IV Colorectal Cancer Phase 1
Recruiting NCT03088150 - COLLISION Trial - Colorectal Liver Metastases: Surgery vs Thermal Ablation N/A